CLARUS THERAPEUTICS HOLDINGS, INC. Operating Expenses
CLARUS THERAPEUTICS HOLDINGS, INC. reported Operating Expenses of $13.54 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2022-08-19
- CLARUS THERAPEUTICS HOLDINGS, INC. operating expenses for the quarter ending 2022-06-30 was $13.54M, a 12.42% decline year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. operating expenses for the quarter ending 2022-03-31 was $16.89M, a 32.49% increase year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. operating expenses for the quarter ending 2021-12-31 was $10.54M, a 3.13% increase year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. operating expenses for the quarter ending 2021-09-30 was $12.21M, a 7.58% decline year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. operating expenses for fiscal 2021 was $50.97M, a 13.62% increase from fiscal 2020.
- CLARUS THERAPEUTICS HOLDINGS, INC. operating expenses for fiscal 2020 was $44.86M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2022-06-30 | $13.54M 10-Q · filed 2022-08-19 | $30.44M 10-Q · filed 2022-08-19 | $40.98M derived: sum of 3 quarters · filed 2022-08-19 | $53.19M derived: sum of 4 quarters · filed 2022-08-19 |
| 2022-03-31 | $16.89M 10-Q · filed 2022-05-16 | $27.44M derived: sum of 2 quarters · filed 2022-05-16 | $39.65M derived: sum of 3 quarters · filed 2022-05-16 | $55.11M derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-12-31 | $10.54M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $22.75M derived: sum of 2 quarters · filed 2022-03-31 | $38.22M derived: sum of 3 quarters · filed 2022-08-19 | $50.97M 10-K · filed 2022-03-31 |
| 2021-09-30 | $12.21M 10-Q · filed 2021-11-19 | $27.67M derived: sum of 2 quarters · filed 2022-08-19 | $40.43M 10-Q · filed 2021-11-19 | $50.65M derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-06-30 | $15.46M 10-Q · filed 2022-08-19 | $28.22M 10-Q · filed 2022-08-19 | $38.44M derived: sum of 3 quarters · filed 2022-08-19 | $51.65M derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-03-31 | $12.75M 10-Q · filed 2022-05-16 | $22.98M derived: sum of 2 quarters · filed 2022-05-16 | $36.19M derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | $10.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $23.43M derived: sum of 2 quarters · filed 2022-03-31 | $44.86M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $13.21M 10-Q · filed 2021-11-19 | $34.64M 10-Q · filed 2021-11-19 |